---
title: "Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights | RVPH Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286313938.md"
description: "Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights | RVPH Stock News"
datetime: "2026-05-13T12:35:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286313938.md)
  - [en](https://longbridge.com/en/news/286313938.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286313938.md)
---

# Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights | RVPH Stock News

Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights | RVPH Stock News

### Related Stocks

- [RVPH.US](https://longbridge.com/en/quote/RVPH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [RVPHW.US](https://longbridge.com/en/quote/RVPHW.US.md)

## Related News & Research

- [Reviva Pharmaceuticals Q1 net loss narrows on lower expenses](https://longbridge.com/en/news/286314912.md)
- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Precigen Q1 revenue beats estimates on PAPZIMEOS launch](https://longbridge.com/en/news/286311056.md)
- [08:00 ETAvance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership](https://longbridge.com/en/news/286094661.md)
- [Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion](https://longbridge.com/en/news/286461579.md)